The Public Interest Declassification Board was established by Congress in 2000 “to promote the fullest possible public access to a thorough, accurate, and reliable documentary record of significant United States national security decisions.” (FY 2001 Intelligence Authorization Act, Section 703).
Six years later, it has still done no such thing.
In its first practical test, members of Congress asked the Board to review the classification of two recent reports on pre-war Iraq intelligence to determine if more of the text could be disclosed.
But the Board concluded that it could not proceed without White House approval, which was not forthcoming.
This week, reported Rebecca Carr of Cox News, the Board asked Congress to modify its charter to make clear that White House approval is not required for this purpose.
See “Anti-secrecy board unable to gain traction” by Rebecca Carr, Cox News Service, December 8.
The Board will hold its next meeting on December 15 at the National Archives in Washington, DC.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.